A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
about
Novel approaches to identify protective malaria vaccine candidatesIn vivo and in vitro characterization of a Plasmodium liver stage-specific promoterPlasmodium falciparum heterochromatin protein 1 marks genomic loci linked to phenotypic variation of exported virulence factorsHepatic phase of malaria: a crucial role as "go-between" with other stagesDiscovery of Novel Plasmodium falciparum Pre-Erythrocytic Antigens for Vaccine DevelopmentLineage-specific expansion of proteins exported to erythrocytes in malaria parasites.Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasitesPlasmodium cellular effector mechanisms and the hepatic microenvironmentIdentification and characterization of a liver stage-specific promoter region of the malaria parasite PlasmodiumComplex Minigene Library Vaccination for Discovery of Pre-Erythrocytic Plasmodium T Cell AntigensAcquired antibody responses against Plasmodium vivax infection vary with host genotype for duffy antigen receptor for chemokines (DARC)Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data.How to select Plasmodium falciparum pre-erythrocytic antigens in an expression library without defined probe.Diagnostic value of a synthetic peptide derived from Echinococcus granulosus recombinant protein.Temperature shift and host cell contact up-regulate sporozoite expression of Plasmodium falciparum genes involved in hepatocyte infection.Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparumCytokine responses to Plasmodium falciparum liver-stage antigen 1 vary in rainy and dry seasons in highland Kenya.Interleukin-10 responses to liver-stage antigen 1 predict human resistance to Plasmodium falciparum.Strategies for designing and monitoring malaria vaccines targeting diverse antigensAnalysis of immune responses against T- and B-cell epitopes from Plasmodium falciparum liver-stage antigen 1 in rodent malaria models and malaria-exposed human subjects in India.Immunogenicity of well-characterized synthetic Plasmodium falciparum multiple antigen peptide conjugates.Plasmodium falciparum liver stage antigen-1 is cross-linked by tissue transglutaminase.A Plasmodium falciparum candidate vaccine based on a six-antigen polyprotein encoded by recombinant poxviruses.Comparison of the antibody responses to Plasmodium vivax and Plasmodium falciparum antigens in residents of Mandalay, MyanmarExoerythrocytic malaria vaccine development: understanding host-parasite immunobiology underscores strategic success.A human Phase I/IIa malaria challenge trial of a polyprotein malaria vaccine.NYVAC-Pf7: a poxvirus-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic.Induction of multi-antigen multi-stage immune responses against Plasmodium falciparum in rhesus monkeys, in the absence of antigen interference, with heterologous DNA prime/poxvirus boost immunization.Cytotoxic T cells recognize a peptide from the circumsporozoite protein on malaria-infected hepatocytes.Allelic forms of gp195, a major blood-stage antigen of Plasmodium falciparum, are expressed in liver stagesVaccine candidate discovery for the next generation of malaria vaccines.A combined transcriptome and proteome survey of malaria parasite liver stages.Malaria vaccine development.A liver-stage specific antigen of P. berghei identified by a monoclonal antibody.Tandemly repeated exons encode 81-base repeats in multiple, developmentally regulated Schistosoma mansoni transcriptsUsefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection.High levels of antibodies to Plasmodium falciparum liver stage antigen-1 in naturally infected individuals in MyanmarGenetic mapping of the chloroquine-resistance locus on Plasmodium falciparum chromosome 7.Recombinant modified vaccinia virus Ankara-based malaria vaccines.
P2860
Q21131082-DDF23C74-6390-4992-B63E-65263102DB93Q27309766-9C8113E4-CAE4-495B-A169-ED8BE1C0DDC3Q27316324-8BC85681-2AF4-4297-86A3-47DD333E8001Q27486094-E549E9C8-01E2-47B6-B1E0-ED57D0E7AF17Q27972709-91699AA4-5C14-48E9-B58F-F16E1EAEDBDCQ27974123-46ED74B6-0F2B-415D-B8BA-A6C4987611CCQ27974558-3F69A031-3D9C-42A3-889B-6CC36AE55F31Q28081143-37CA5C6B-640E-42F5-B815-D4556B1B4757Q28475936-B3523790-16A8-4FB3-A507-9E916A34A0A6Q28551311-6BE27BBB-7B3E-44FE-8D5A-20FD59712713Q28750566-3A4217DF-DFEF-4DA2-BF1F-F753F9CE8638Q30814677-FF516957-AB9E-468F-8C6B-C4DA28731F77Q33263347-6F7EE7D6-99D8-4533-B636-AE1F220969BBQ33279659-3130B99A-1A8F-4B80-8C66-B42AD3CD1C7CQ33358681-A90D92AC-C3C7-4CFF-916B-5DBD93F9F037Q33521214-76DD0BCB-FBBC-4E5A-93C6-18157BF3CD6AQ33599649-3DCA17FE-108B-4FA4-B8FD-557951C6FAF7Q33876788-2B2E6700-2594-44AA-BD65-49201B2A5769Q33959038-BF926890-D141-4177-BD2C-FC131D3DABB4Q34002992-02119605-7FBB-48F2-8376-886600AFA7F7Q34008562-53A7851A-A922-4A39-8089-53DD76EDB532Q34567297-46987104-3790-4269-8987-E2C3499D1D57Q35122498-0E5362F7-BF20-4A7B-B6BD-4DA09D235AB6Q35186079-407204B2-E28E-4E77-B42B-9C8FE621BF78Q35193463-E13F8F45-106D-4D73-8E8D-A9A48E7D1668Q35367108-264593BA-DE9A-4597-86CD-F62B55FDD988Q35519418-C510D877-6EA9-482D-AFF7-92058BDEA12AQ35560038-CABE28EF-7C00-4578-A37D-D91298BBF430Q36285998-871F25A7-5EC9-4B5D-AD79-D8ABEC16E8B2Q36350636-18DF1A1F-EF9F-4630-A110-C1707B392568Q36354328-A70C5A89-CE55-4EE2-B9DF-739BB5DA6614Q36413834-C70BEFC5-57E6-4BAC-88DC-F21C17E74EB7Q36423509-3BA79D52-0F8E-48FC-9651-76EEFF8B9FFCQ36641624-7FB7C2EB-DA96-45CA-9BB6-EABAA536D54CQ36668538-28F16A31-2406-480B-8552-51E89C3FAC60Q36848801-E85E999E-D68C-4C23-8CF5-02F204552CB3Q36868249-165E95F8-8CDA-4962-B4A8-741A3556C200Q36908779-1EE3F347-4BD3-4DE1-9A1A-640B2FF1923FQ37485888-CDA3248C-FFC5-45FB-91B5-AAC34A83ABDAQ38618898-32B0D16B-B91A-4837-86A7-2D4CB6B95E96
P2860
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年学术文章
@wuu
1987年学术文章
@zh
1987年学术文章
@zh-cn
1987年学术文章
@zh-hans
1987年学术文章
@zh-my
1987年学术文章
@zh-sg
1987年學術文章
@yue
1987年學術文章
@zh-hant
name
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@en
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@nl
type
label
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@en
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@nl
prefLabel
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@en
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@nl
P2093
P921
P356
P1433
P1476
A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning.
@en
P2093
Beaudoin RL
Guerin-Marchand C
Langsley G
Mercereau-Puijalon O
Patarapotikul J
P2888
P304
P356
10.1038/329164A0
P407
P577
1987-09-01T00:00:00Z
P5875
P6179
1048094588